Concepts (106)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Telemedicine | 4 | 2019 | 169 | 0.890 |
Why?
|
| Glaucoma, Neovascular | 1 | 2021 | 5 | 0.840 |
Why?
|
| Glaucoma Drainage Implants | 1 | 2020 | 8 | 0.750 |
Why?
|
| Ophthalmology | 2 | 2017 | 39 | 0.710 |
Why?
|
| Prosthesis Implantation | 1 | 2020 | 125 | 0.680 |
Why?
|
| Pseudotumor Cerebri | 1 | 2017 | 16 | 0.590 |
Why?
|
| Remote Consultation | 1 | 2017 | 16 | 0.590 |
Why?
|
| Retina | 1 | 2017 | 213 | 0.510 |
Why?
|
| Delivery of Health Care | 3 | 2019 | 426 | 0.360 |
Why?
|
| Tomography, Optical Coherence | 3 | 2020 | 130 | 0.350 |
Why?
|
| Glaucoma | 2 | 2019 | 30 | 0.350 |
Why?
|
| Cataract | 2 | 2019 | 86 | 0.340 |
Why?
|
| Macular Degeneration | 2 | 2019 | 59 | 0.330 |
Why?
|
| Diabetic Retinopathy | 2 | 2019 | 87 | 0.330 |
Why?
|
| Bufanolides | 2 | 2018 | 5 | 0.300 |
Why?
|
| Visual Acuity | 3 | 2020 | 194 | 0.260 |
Why?
|
| Nerve Fibers | 2 | 2020 | 46 | 0.230 |
Why?
|
| Retinal Ganglion Cells | 2 | 2020 | 66 | 0.230 |
Why?
|
| Eye Burns | 1 | 2020 | 5 | 0.200 |
Why?
|
| Resistance Training | 1 | 2020 | 13 | 0.200 |
Why?
|
| Keratitis | 1 | 2020 | 22 | 0.190 |
Why?
|
| Glaucoma, Open-Angle | 1 | 2020 | 17 | 0.190 |
Why?
|
| Eye Injuries | 1 | 2020 | 15 | 0.190 |
Why?
|
| Wet Macular Degeneration | 1 | 2020 | 25 | 0.190 |
Why?
|
| Retrospective Studies | 4 | 2021 | 8489 | 0.190 |
Why?
|
| Cornea | 1 | 2020 | 69 | 0.190 |
Why?
|
| Disease Transmission, Infectious | 1 | 2020 | 57 | 0.180 |
Why?
|
| Equipment Failure | 1 | 2020 | 119 | 0.180 |
Why?
|
| Ultraviolet Rays | 1 | 2020 | 193 | 0.180 |
Why?
|
| Prospective Studies | 3 | 2021 | 4213 | 0.160 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2020 | 311 | 0.160 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2018 | 78 | 0.160 |
Why?
|
| Fibrosis | 1 | 2018 | 203 | 0.150 |
Why?
|
| Veterans Health | 1 | 2017 | 15 | 0.150 |
Why?
|
| Biomedical Technology | 1 | 2017 | 20 | 0.150 |
Why?
|
| Eye Diseases | 1 | 2017 | 53 | 0.140 |
Why?
|
| Ocular Hypertension | 3 | 2020 | 7 | 0.140 |
Why?
|
| Carica | 1 | 2015 | 1 | 0.130 |
Why?
|
| Chromosomes, Plant | 1 | 2015 | 33 | 0.130 |
Why?
|
| Kidney Diseases | 1 | 2018 | 418 | 0.120 |
Why?
|
| Pandemics | 1 | 2020 | 740 | 0.120 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2015 | 134 | 0.120 |
Why?
|
| Genetic Loci | 1 | 2015 | 250 | 0.120 |
Why?
|
| Child, Preschool | 1 | 2020 | 3612 | 0.110 |
Why?
|
| Humans | 10 | 2021 | 86643 | 0.110 |
Why?
|
| Haplotypes | 1 | 2015 | 642 | 0.110 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 1565 | 0.110 |
Why?
|
| Male | 8 | 2020 | 40965 | 0.090 |
Why?
|
| Risk Factors | 1 | 2020 | 5417 | 0.090 |
Why?
|
| Treatment Outcome | 1 | 2021 | 7993 | 0.090 |
Why?
|
| Child | 1 | 2020 | 6927 | 0.080 |
Why?
|
| Adult | 5 | 2020 | 25648 | 0.080 |
Why?
|
| Adolescent | 1 | 2020 | 8981 | 0.080 |
Why?
|
| Aged | 6 | 2020 | 18415 | 0.080 |
Why?
|
| Referral and Consultation | 2 | 2019 | 328 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2017 | 2601 | 0.070 |
Why?
|
| Middle Aged | 6 | 2020 | 25028 | 0.070 |
Why?
|
| Heart Failure | 1 | 2015 | 1204 | 0.070 |
Why?
|
| Sensitivity and Specificity | 2 | 2019 | 1991 | 0.060 |
Why?
|
| Female | 7 | 2020 | 44532 | 0.060 |
Why?
|
| Reproducibility of Results | 2 | 2019 | 2705 | 0.060 |
Why?
|
| Tonometry, Ocular | 1 | 2020 | 10 | 0.050 |
Why?
|
| Exudates and Transudates | 1 | 2020 | 14 | 0.050 |
Why?
|
| Slit Lamp Microscopy | 1 | 2020 | 5 | 0.050 |
Why?
|
| Intraocular Pressure | 1 | 2020 | 54 | 0.050 |
Why?
|
| Intravitreal Injections | 1 | 2020 | 67 | 0.050 |
Why?
|
| Visual Fields | 1 | 2020 | 98 | 0.050 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 6509 | 0.050 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2019 | 27 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2020 | 407 | 0.040 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2018 | 37 | 0.040 |
Why?
|
| Veterans | 1 | 2019 | 72 | 0.040 |
Why?
|
| Ouabain | 1 | 2018 | 24 | 0.040 |
Why?
|
| Physical Examination | 1 | 2019 | 149 | 0.040 |
Why?
|
| MAP Kinase Signaling System | 1 | 2018 | 192 | 0.040 |
Why?
|
| Georgia | 1 | 2017 | 34 | 0.040 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2017 | 26 | 0.040 |
Why?
|
| Swine | 1 | 2018 | 555 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2020 | 484 | 0.040 |
Why?
|
| Health Services | 1 | 2017 | 55 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2018 | 1106 | 0.030 |
Why?
|
| Genes, Plant | 1 | 2015 | 99 | 0.030 |
Why?
|
| Cell Line | 1 | 2018 | 2468 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 455 | 0.030 |
Why?
|
| Genetic Linkage | 1 | 2015 | 623 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2017 | 394 | 0.030 |
Why?
|
| Mice | 2 | 2018 | 11352 | 0.030 |
Why?
|
| Stroke Volume | 1 | 2015 | 456 | 0.030 |
Why?
|
| Genetics, Population | 1 | 2015 | 394 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2015 | 1074 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2015 | 1538 | 0.030 |
Why?
|
| Alleles | 1 | 2015 | 1128 | 0.030 |
Why?
|
| Quantitative Trait Loci | 1 | 2015 | 576 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2015 | 819 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 1673 | 0.020 |
Why?
|
| Heart Transplantation | 1 | 2015 | 705 | 0.020 |
Why?
|
| Hospitalization | 1 | 2015 | 849 | 0.020 |
Why?
|
| Biomarkers | 1 | 2015 | 1718 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2015 | 813 | 0.020 |
Why?
|
| Young Adult | 1 | 2020 | 5976 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 3092 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2015 | 2767 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 2232 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2018 | 3241 | 0.020 |
Why?
|
| Animals | 2 | 2018 | 26582 | 0.020 |
Why?
|
| United States | 1 | 2017 | 6672 | 0.020 |
Why?
|